BCR and B-cell chronic lymphocytic leukemia: We demonstrated that pharmacologic inhibition of the BCR pathway in patients with CLL induces off-target genomic mutagenesis mediated by AID, expanding prior observations of PI3Kδ-blockade-induced genomic instability [17].